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Abstract
Background: Patients with inflammatory bowel disease have lifelong needs to learn how to manage their
symptoms and life situation. The range of actions that patients take in order to manage daily life and maintain
health is referred to as self-care. Assessment of self-care inpatients with inflammatory bowel disease could
allow targeted support and education by health care professionals.There are no existing measures assessing
self-care in patients with inflammatory bowel disease.
Objectives: The aim was to develop and evaluate the self-care questionnaire for assessment of self-care among
patients with inflammatory bowel disease.
Methods: Qualitative and quantitative methods were used to develop inflammatory bowel disease self-care
questionnaire. The development and evaluation process was performed in three phases: (1) item generation
based on interviews with patients with inflammatory bowel disease(n=20), (2) content validation in a panel
of experts (n=6) and patients(n=100) assessed with the content validity index, cognitive interviews and
quantifying and ranking the items to determine the usability of the questionnaire, and (3) final evaluation
through a pilot study (n=93) with test-retest evaluation (n=50). An expert review group of three nurses and
one physician continuously discussed the result during the development process.
Results: A total of 91 patients with Crohn's disease and 102 with ulcerative colitis participated. The final self-
care questionnaire consists of 22 items. Assessment of content validity indicated that the items were adequate
and easy to understand. Test-retest reliability was confirmed with intraclass correlations above 0.6 after a three
week interval, for all items except one.
Conclusion: An inflammatory bowel disease-specific self-care questionnaire was developed using structured
methods. The evaluation indicated good validity and reliability. The questionnaire may be a useful tool to
assess the ability of patients with inflammatory bowel disease to perform routine self-care.
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Development of a self-care questionnaire for clinical assessment of self-care 
in patients with inflammatory bowel disease: A psychometric evaluation 
Abstract 
Background: Patients with inflammatory bowel disease have lifelong needs to learn how to 
manage their symptoms and life situation. The range of actions that patients take in order to 
manage daily life and maintain health is referred to as self-care. Assessment of self-care in 
patients with inflammatory bowel disease could allow targeted support and education by 
health care professionals. There are no existing measures assessing self-care in patients with 
inflammatory bowel disease.  
Objectives: The aim was to develop and evaluate the self-care questionnaire for assessment of 
self-care among patients with inflammatory bowel disease.   
Methods: Qualitative and quantitative methods were used to develop inflammatory bowel 
disease self-care questionnaire. The development and evaluation process was performed in 
three phases: (1) item generation based on interviews with patients with inflammatory bowel 
disease (n=20), (2) content validation in a panel of experts (n=6) and patients (n=100) 
assessed with the content validity index, cognitive interviews and quantifying and ranking the 
items to determine the usability of the questionnaire, and (3) final evaluation through a pilot 
study (n=93) with test-retest evaluation (n=50). An expert review group of three nurses and 
one physician continuously discussed the result during the development process.  
Results: A total of 91 patients with Crohn's disease and 102 with ulcerative colitis 
participated. The final self-care questionnaire consists of 22 items. Assessment of content 
validity indicated that the items were adequate and easy to understand. Test-retest reliability 
was confirmed with intraclass correlations above 0.6 after a three week interval, for all items 
except one.  
Conclusion: An inflammatory bowel disease-specific self-care questionnaire was developed 
using structured methods. The evaluation indicated good validity and reliability. The 
questionnaire may be a useful tool to assess the ability of patients with inflammatory bowel 
disease to perform routine self-care. 
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What is already known about the topic? 
 Patients need planning their life to be able to participate in daily activities.  
 
 Health care professionals must consider patients’ potential and desire for self-care 
when giving advice on self-care activities. Doing so may be effective in promoting a 
healthier life-style. 
 
'What does this paper adds?'  
 This paper presents the first questionnaire to assess self-care in patients with 
inflammatory bowel disease. 
 
 Self-care may be increased by support from health-care professionals by using the 
inflammatory bowel disease specific self-care questionnaire. 
 
INTRODUCTION 
Inflammatory bowel disease including Crohn´s disease and ulcerative colitis are chronic 
conditions involving inflammation of the gastrointestinal tract (Gomollon et al., 2016). There 
is increasing incidence and prevalence of inflammatory bowel disease around the world and 
the highest incidence is in northern Europe (Burisch et al., 2014, Kaplan, 2015, Molodecky et 
al., 2012). 
Patients with inflammatory bowel disease experience both physical and psychological 
symptoms, especially when the disease is active (Farrell et al., 2016). The symptoms depend 
on the activity of the inflammation, disease location and intestinal complications. The disease 
activity varies over time and remission is often followed by periods of relapse. The most 
burdensome symptoms are diarrhea, bowel urgency, abdominal pain and lack of energy 
(Farrell et al., 2016, Gomollon et al., 2016). Psychological symptoms, such as anxiety and 
depression, are also common among persons living with inflammatory bowel disease, 
although the pathophysiology underlying the interaction between psychological symptoms 
and inflammatory bowel disease is unknown (Bernstein, 2016). The inflammatory bowel 
disease symptoms may constrain the ability to perform everyday activities, causing worry and 
concern about the future and thereby also affecting quality of life (Devlen et al., 2014, Faust 
et al., 2012, Pihl-Lesnovska et al., 2010).  
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To manage daily life, patients with inflammatory bowel disease need to maintain 
physical as well as psychological health through the use of self-care (O'Connor et al., 2013, 
Van Assche et al., 2013). Self-care is a process by which patients can maintain and improve 
their health (Riegel et al., 2012). Self-care has been shown to be associated with better 
treatment outcomes and higher life satisfaction (Plevinsky et al., 2016, Strömberg A, 2012). 
However, self-care can have different meanings for patients and may not necessarily be 
consistent over time (Riegel et al., 2012). 
       Self-care for patients with inflammatory bowel disease focuses on factors that can prevent 
relapses, relieve symptoms or help with managing daily life. Patients engage in a range of 
activities such as taking medication, restricting diet, modifying behaviors that could trigger 
symptoms, and maintaining close proximity to a toilet (Devlen et al., 2014). A previous study 
showed that self-care for patients with  inflammatory bowel disease could be divided into four 
categories: symptom recognition, symptom management, planning life, and seeking new 
options (Lovén Wickman et al., 2016). Patients with inflammatory bowel disease have 
lifelong needs to learn how to manage their symptoms and situations (Lesnovska et al., 2014). 
Being one step ahead and planning make life with  inflammatory bowel disease easier (Lovén 
Wickman et al., 2016).  
A variety of approaches and theoretical perspectives for self-care interventions have 
been used in inflammatory bowel disease research, and self-care has been deemed important 
for patients with inflammatory bowel disease (Conley and Redeker, 2016). Self-care 
interventions such as web-based health care plans have increased treatment adherence and 
disease knowledge as well as disease-specific quality of life (Elkjaer, 2012).  
Promotion of self-care is best performed following a holistic assessment in which the 
patients perspective and priorities are determined (Kralik et al., 2010). Health care 
professionals can help patients with inflammatory bowel disease by acknowledging that self-
care is a process that gradually evolves. Physicians and nurses need to acknowledge the 
patients desires and abilities when they give advice on self-care (Conley and Redeker, 2016). 
To identify the need of advice and support, the patient’s self-care abilities must be assessed. 
  Self-care assessments for chronic diseases other than inflammatory bowel disease have 
been developed (Riegel et al., 2009). Questionnaires for assessment of self-efficacy regarding 
knowledge, medication use and skills have previously been developed for patients with 
inflammatory bowel disease (Zijlstra et al., 2013). However, a validated questionnaire 
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designed to assess self-care of inflammatory bowel disease is lacking and the National Board 
of Health and Welfare regulations in Sweden has called for the development of a 
questionnaire for clinical assessment of self-care (National Board of Health and Welfare, 
2009). To be useful in clinical practice, such a questionnaire needs to be relevant to both 
patients and health care professionals, and the questions should be easy to understand and 
respond to by patients 
 
AIM 
The aim of this study was to develop and evaluate a questionnaire for assessment of self-care 
among patients with inflammatory bowel disease. 
 
METHODOLOGY  
Design 
The self-care questionnaire was developed and evaluated using qualitative and quantitative 
methods (Polit and Beck, 2012, Streiner et al., 2014).The development and evaluation process 
was performed in three phases during the period of 2013 to 2016 (Figure 1), and the first 
phase (phase 1a, 1b) was previously published (Lovén Wickman et al., 2016). An expert 
review group with three nurses and one physician continuously discussed the results during 
the process of developing the self-care questionnaire. 
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Figure 1. Inflammatory bowel disease self-care questionnaire development and 
evaluation 
Participants  
Adult patients with inflammatory bowel disease from three gastroenterology clinics in south-
eastern Sweden were invited to participate (phase II and phase III, Figure 1). If they agreed to 
participate they returned a written consent form and the completed questionnaires in a 
postage-paid return envelope. The characteristics of patients who participated in the three 
study phases are shown in Table 1.  
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Table 1. Patient characteristics in phases II and III 
                                                          Patient validation Pilot study Test-retest 
 
 
phase II 2c 
n=100 
 
phase III 3a 
n=93 
 
phase III 3b 
n=50 
Age, median (range)  54 (18-83) 48 (19-77) 48 (20-77) 
Gender, n (%)    
Men 52 (52) 48 (52) 28 (56) 
Women 48 (48) 45 (48) 22 (44) 
Diagnosis, n (%)    
Crohn´s disease 51 (51) 40 (43) 19 (38) 
Ulcerative colitis  49 (49) 53 (57) 31 (62) 
Years since diagnosis, median 
(range) 
13 (0.5-54) 10 (0-62) 10 (0.5-47) 
Marital status, n (%)    
Married/cohabiting 66 (66) 71 (76) 39 (78) 
Living alone 28 (28) 17 (18) 8 (16) 
Other alternatives 6 (6) 
 
5 (6) 3 (6) 
 
Education level, n (%)    
Compulsory school  32 (32) 18 (19) 10 (20) 
Upper secondary school 29 (29) 43 (46) 25 (50) 
High school or university level 39 (39) 31 (34) 14 (28) 
Item non-response   1 (1) 1 (2) 
Occupation, n (%)    
Full-time 38 (38) 47 (51) 25 (50) 
Part-time 10 (10) 11 (12) 7 (14) 
Retired 41 (41) 18 (20) 11 (22) 
Unemployed 1 (1) 6 (7) 4 (8) 
Sick-leave 4 (4) 5 (5) 2 (4) 
Item non-response 6 (6) 6 (5) 1 (2) 
Surgical procedures n (%)    
Surgery  42 (42) 26 (28) 12 (24) 
No surgery  56 (56) 67 (72) 37 (74) 
Item non-response 2 (2)  1 (2) 
 
The health care professionals in the early evaluation (Phase 2a, Figure 1) included three 
clinical nurses and three physicians (age range 41-59) from four hospitals, with long clinical 
experience (11-37 years) of inflammatory bowel disease patient care. Four of the health care 
professionals had academic and research experience. The participants in the cognitive 
interviews (Phase 2b, Figure 1) included three patients with inflammatory bowel disease (ages 
53, 65, 74 years). 
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Measurement and statistical methods 
The patients in the validation, pilot study and test-retest phases (Table 1) answered a 
questionnaire including the self-care questions as well as questions on their characteristics 
such as gender, age, diagnosis, duration of inflammatory bowel disease, education, occupation 
and previous surgery.  In test-retest (phase 3b, Figure 1) patients also completed a symptom 
registration form with nine items to calculate two validated disease activity indices. The 
Simple Clinical Colitis Activity Index was used for ulcerative colitis (scores ≤5 indicating 
remission) (Walmsley et al., 1998). The Harvey Bradshaw index was used for Crohn’s 
disease. The Harvey Bradshaw index was modified, excluding abdominal mass, to enable 
self-assessment in this postal survey (scores ≤ 5 indicating remission) (Harvey and Bradshaw, 
1980).  
Descriptive statistics were used for patient characteristics, the self-care items and 
symptom registration. Continuous variables are presented as median and percentiles or range, 
and categorical variables are presented as numbers and frequencies (%). In addition, validity 
was assessed in terms of face validity (interview study, health care professionals and patient 
validation) and content validity (literature search, interview study, health care professionals 
and patient validation). 
Content validity index was used to assess content validity in the health care 
professionals validation phase (Lynn, 1986, Polit and Beck, 2006, Polit et al., 2007). The 
content validity index for each item was calculated as the percentage of experts rating the item 
as often or always relevant. The lowest accepted value of the content validity index was 0.83, 
assuming that at least five of the six experts would rate an item as often or always relevant.  
(Lynn, 1986, Polit and Beck, 2006).   
Percentage agreement was used to assess test-retest stability using frequency and 
percentage for test and retest (Bland and Altman, 1986, Field, 2014). A percentage agreement 
> 70% was considered acceptable.  
Intraclass correlation coefficient was used as a measure of test-retest reliability that 
account for systematic error (Koo and Li, 2016). An intraclass correlation coefficient close to 
1 indicates high similarity between items and low intraclass correlation coefficient close to 
zero means low similarity. An intraclass correlation coefficient more than 0.6 was considered 
as acceptable (Weir, 2005). In retest, patients responded to an additional question asking if 
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they had implemented a change in self-care after the first test. A Wilcoxon signed rank test 
was used to explore the difference in disease activity at baseline and after three weeks in the 
test-retest evaluation.  
The data were analyzed using Excel, and SPSS, the statistical package version 23-24 for 
Windows (IBM SPSS Inc, Chicago, IL US).  
QUESTIONNAIRE DEVELOPMENT AND EVALUATION 
Phase I - Item generation  
To explore relevant themes and issues regarding self-care for patients with inflammatory 
bowel disease, an overview of the literature was performed. Then we analyzed an interview 
study with qualitative content analysis to explore self-care among patients with inflammatory 
bowel disease (n=20) (phase 1b, Figure 1) (Lovén Wickman et al., 2016). Based on this study 
and a continuously updated literature search, items to describe self-care for inflammatory 
bowel disease were generated. This phase led to a first draft of the self-care questionnaire 
with 51 items (phase 1c, Figure 1). 
Phase II - Early evaluation  
Health care professional validation 
The first version of the questionnaire with 51 items was evaluated by health care 
professionals. They were given information about the study, the items of the questionnaire 
and instructions on how to assess each item. They were asked to consider the relevance of 
each item by rating it on a four-point ordinal scale: (1) not relevant, (2) sometimes relevant; 
(3) often relevant; (4) always relevant. They were also asked to consider whether the 
questionnaire measured all important aspects of self-care among patients with inflammatory 
bowel disease and to reflect on improvements of the present items as well as suggesting new 
items (phase 2a, Figure 1). 
 The content validity index for the whole questionnaire was 0.55 while 22 items had 
content validity index for the items ≥ 0.83 (Polit and Beck, 2006). The remaining 29 items 
(range 0.17-0.67) were discussed in the expert review group, with a decision to keep them to 
ensure that the patients evaluations of items were considered in the final selection of items. In 
two cases two items with similar content were combined into a single item. One item (avoid 
sex) was added. 
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Cognitive interviews 
Thereafter, cognitive interviews with three patients with inflammatory bowel disease were 
performed (phase 2b, Figure 1). All participants agreed and gave both written and oral 
consent. The interviews took place in a health care setting with the first author. The interview 
started with a think-aloud phase which was followed by retrospective probes such as “Can 
you tell me more about…”.The cognitive interviews were audio-recorded and transcribed 
verbatim and analyzed by discussion in the expert review group (Collins, 2015). A few 
difficulties in understanding the items emerged and reformulations were made to some items. 
For example: I know who I will turn to when I do not feel well was changed to Do you know 
whom to contact if you experience symptoms of inflammatory bowel disease? and I change my 
medical treatment based on my own decisions? changed to Do you take medication for 
inflammatory bowel disease as prescribed by a doctor? 
 
Patient validation  
Data were consecutively collected during 2015 and 2016 at three gastroenterology clinics in 
southeastern Sweden (Table 1). The invitation to participate was offered to 100 patients for 
validation by both physicians and nurses (phase 2c, Figure 1). The patients were asked to 
answer, on an ordinal scale, how often they performed the different self-care: (1) never, (2) 
sometimes, (3) often, or (4) always. The patients were also invited to suggest improvements 
for the items and to suggest new items. The median age of the participants was 54 years, the 
range being 18-83 years (Table 1). There was no purposeful selection of patients in terms of 
age, gender or socioeconomic factors. Item non-response was low in the returned 
questionnaires (0-3%) and no new items were suggested by the patients (phase 2c, Figure 1).  
At the end of phase II, the expert review group made a final evaluation and items were 
put together into the final form of the self-care questionnaire. There was a consensus on the 
relevance of issues according to patients and health care professionals (phase 2a, Figure 1) 
and the final questionnaire consists mainly of the issues with a content validity index ≥ 0.83 
and most commonly used by patients. In some cases, several more detailed items were 
covered by a single overarching item in the final questionnaire for example, an item 
addressing diet adaptations. The expert review group judged it as reasonable that the items on 
tobacco use, avoiding alcohol, avoiding sex and use of natural remedies should remain in the 
questionnaire even if they were relatively uncommon among the patients since they could 
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contribute to a more comprehensive picture of patient’s self-care. Also, a question on 
confidence in determining whether intestinal symptoms are due to inflammatory bowel 
disease were added as ability to assess intestinal symptoms is basic in inflammatory bowel 
disease self-care. 
The expert review group also decided to keep the two items to be near a toilet and pay 
attention to psychological symptoms since these were common among patients. The final 
revision was also focusing on getting the questions to work together as a comprehensive 
questionnaire. Two summarizing questions were therefore added on other performed self-care 
and how often self-care is helpful to relieve symptoms.  
Phase III - Final evaluation 
Data for the pilot study and the test-retest study were consecutively collected between 2015 
and 2016 from a total of 93 patients with inflammatory bowel disease. These patients were 
enrolled from three gastroenterology clinics in south-eastern Sweden (Phase 3, Figure 1, 
Table 1).  
Pilot study  
The pilot study was initially intended to test the final version and the layout of the 
questionnaire before the test-retest (phase 3b, Figure 1). After the first 30 patients, a brief 
evaluation was conducted, which showed that the questionnaire and layout was working well. 
A decision was then made to regard this as the final version and continue the pilot study while 
also inviting patients to participate in the test-retest evaluation (phase 3b, Figure 1). 
Altogether, 93 patients participated in the pilot study, of which 63 also were invited to do the 
test-retest validation. Out of the 93 patients in the pilot study, 90 completed all items in the 
questionnaire. There were no answers or comments indicating problems understanding or 
answering the questions. Patients were able to answer the questions and there were few 
comments about unclear items and no comments about aspects missing in the questionnaire. 
Thus, the questionnaire seems to reflect a valid view of a patient’s self-care.  
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Table 2. The final items of the inflammatory bowel disease- specific self-care 
questionnaire (nine questions including 22 items) 
1. Do you pay attention to symptoms of inflammatory bowel disease? 
I pay attention to intestinal symptoms/physical symptoms unrelated to the 
intestines/psychological symptoms 
Scored: from 1 (never) to 4 (always) and 5 (not applicable) 
2. How often do you feel confident that you are able to determine whether 
intestinal symptoms are due to inflammatory bowel disease? 
Scored: from 1 (never) to 4 (always) and 5 (not applicable) 
3. How often do you adapt your day to problems caused by inflammatory bowel 
disease? 
I adapt my diet, I avoid various activities, I avoid sex, I avoid alcohol, I plan my day so 
that I am always near a toilet, I plan my day in view of the fact that I have inflammatory 
bowel disease Scored: from 1 (never) to 4 (always) and 5 (not applicable) 
4. How often do you administer self-care to prevent or relieve symptoms of 
inflammatory bowel disease? Self-care to make sure I sleep well, self-care to manage 
stress, I find out more about inflammatory bowel disease, I look for new approaches to 
living with inflammatory bowel disease, I use natural remedies, I perform other self-
care. 
Scored; from 1 (never) to 4 (always) and 5 (not applicable) 
5. Do you take medication for inflammatory bowel disease as prescribed by a 
doctor? 
Scored: from 1 (never) to 4 (always) and 5 (no prescription of medication), 
6. Do you know whom to contact if you experience symptoms of inflammatory 
bowel disease? 
Scored: from 1 (no) and 2 (yes), 
7. How familiar are you with the symptoms for which you should contact a 
healthcare provider? 
Scored: from 1 (not familiar) to 4 (totally familiar) 
8. Tobacco use: Do you smoke? Do you use snuff? 
Scored: from 1 (daily use) to 4 (I never have) 
9. How often does self-care help you relieve symptoms of inflammatory bowel 
disease? 
Scored: from 1 (never) to 4 (always) and 5 (not applicable) 
 
Test-retest reliability 
For those 63 patients who consented to participate in the test-retest part of the pilot study, the 
second (retest) self-care questionnaire was sent after 15-17 days and 50 patients responded to 
both questionnaires within 3-4 weeks (Bland and Altman, 1986, Field, 2014) (phase 3b, 
Figure 1). 
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Disease activity was measured using appropriate clinical disease activity indices (Phase 3b, 
Figure 1) (Harvey and Bradshaw, 1980, Walmsley et al., 1998). One patient was excluded due 
to incomplete symptom registration. No significant differences in disease activity were shown 
between baseline and after three weeks, either for patients with Crohn’s disease or ulcerative 
colitis (Table 3). However, all patients had low disease activity both in the test and retest.  
 
Table 3. Disease activity indices for with Crohn´s disease and ulcerative colitis  
Harvey–Bradshaw Index* (n=22)   
Median (Q1,Q3) Test 
Median (Q1,Q3) Retest 
5.5 (1-8) 
4.5 (2-7.25) 
Range test  
Range retest 
0-15 
0-15 
Simple Clinical Colitis Activity Index* * (n=27)   
Median (Q1,Q3) test 
Median (Q1,Q3) retest 
2 (0-3) 
1 (0-3) 
Range test 
Range retest 
0-10 
0-8 
* Harvey–Bradshaw Index for patients with CD 
* *Simple Clinical Colitis Activity Index for patients with UC 
In the retest, participants were asked an additional specific question if they had changed their 
self-care since the last time they filled out the questionnaires. Two persons reported that they 
had changed their self-care during the three-week period with more accurate medication usage 
and a modified diet. Test-retest statistics of all responses on each item showed 72-98 % 
agreement between test and retest. Excluding those two patients who had changed their self-
care, the percentage agreement increased to 75-100%. Intraclass correlation coefficients were 
over 0.6, except for one item: I plan my day in view of the fact that I have inflammatory 
bowel disease (Table 4). 
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Table 4. Intraclass correlation coefficient 
 
 
 
 
 
Item Self-care Intraclass correlation  
(95% confidence interval) 
1a. I pay attention to intestinal symptoms .855(.758-.915) 
1b. I pay attention to physical symptoms unrelated to the intestines .667(.482-.796) 
1c. I pay attention to psychological symptoms .882(.802-.932) 
2. How often do you feel confident that you are able to determine whether 
intestinal symptoms are due to inflammatory bowel disease 
.673(.487-.801) 
3a. I adapt my diet .749(.595-.849) 
3b. I avoid various activities .757(.607-.855) 
3c. I avoid sex .681(.499-.805) 
3d. I avoid alcohol .928(.876-.958) 
3e. I plan my day so that I am always near a toilet .789(.656-.875) 
3f. I plan my day in view of the fact that I have inflammatory bowel 
disease 
.426(.178-.626) 
4a. Self-care to make sure I sleep well,  .742(.585-.845) 
4b. Self-care to manage stress, .788(.652-.874) 
4c. I find out more about inflammatory bowel disease .839(.734-.905) 
4d. I look for new approaches to living with inflammatory bowel disease .815(.695-.891) 
4e. I use natural remedies .827(.714-.896) 
5. Do you take medication? .874(.788-.926) 
6. Do you know whom to contact? 1.000 
7. How familiar are you with the symptoms for which you should contact 
a healthcare provider? 
.879(.797-.929) 
8a. Do you smoke? .954 (.921-.974) 
8b. Do you use snuff? .917(.859-.952) 
9. How often does self-care help you relieve symptoms of inflammatory 
bowel disease? 
.847(.744-.911) 
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Ethical considerations 
Approval was obtained from the Regional Ethical Review Board in Linköping University 
(Study code: 2011/288-32, 2012/161-32, 2014/366-31 and 2015/369-31). All participants 
gave their informed consent and confidentiality for the participants was accomplished (WMA, 
2013).  
 
DISCUSSION 
To the best of our knowledge, this is the first study to develop and validate a questionnaire for 
assessment of self-care among patients with inflammatory bowel disease. It resulted in a 
disease-specific self-care questionnaire consisting of 22 items. The early and final evaluation 
of the questionnaire showed good content validity and test-retest reliability in a Swedish 
population.  
 
Importance of involving both patients and health care professional in the development 
process  
To become engaged when answering a questionnaire, patients often emphasize the importance 
of being able to contribute relevant and correct information (Wenemark et al., 2010). Starting 
out with an interview study ensured that patients points of view were given high priority early 
in the process (Lovén Wickman et al., 2016). Keeping all the items during the cognitive 
interviews and the patient validation process was important in order to rigorously value the 
patients’ perspectives. Patient involvement is important to achieve a useful questionnaire that 
minimizes measurement errors due to misinterpretations. In this study, cognitive interviews 
were used to ensure that the items were easy to understand and respond to (Collins, 2015). 
Other questionnaires have relied only on assessments of content validity index from the health 
care professionals perspective which may differ from the patients perspective (Johnson et al., 
2015), although this was not found in our study. Involving health care professionals is 
important as they will discuss and give advice on self-care to the patient based on the patients’ 
responses to the items. The health care professionals are responsible for giving accurate, 
sufficient and timely information and support in a culturally appropriate way to the patients. 
Accordingly, health care professionals involvement during the development process of the 
questionnaire is important as they have disease-specific knowledge, have experience 
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advocating self-care among patients with inflammatory bowel disease, and know what 
information is valuable to the patients in their clinical practice (O'Connor et al., 2013). 
 
Theoretical perspective of the content of the inflammatory bowel disease self-care 
questionnaire 
The results of this study are consistent with the middle range theory for self-care in chronic 
illness (Riegel et al., 2012). Self-care maintenance corresponds to the inflammatory bowel 
disease self-care questionnaire items such as adapt diet, take prescribed medication and plan 
the day. Symptom monitoring is related to items about paying attention to and recognizing 
symptoms related to inflammatory bowel disease itself, associated extra-intestinal 
manifestations, side-effects or psychological or psychiatric disorders. Self-care management 
is related to items about self-care to prevent or relieve symptoms, knowing whom to contact if 
symptoms worsen, and how often self-care helps to relieve symptoms. Another factor of 
importance for self-care is confidence (Riegel et al., 2012) and the inflammatory bowel 
disease self-care questionnaire includes an item about how often the patient feels confident in 
determining whether intestinal symptoms are due to inflammatory bowel disease. 
 
Methodological strengths and limitations 
It can be problematic to find a balance between bringing all items together in a questionnaire 
and obtaining a manageable number of items. However, one strength of this questionnaire is 
the high degree of consistency between the health care professionals’ assessment of item 
relevance and the patients’ assessment of the frequency of different self-care. This ensures 
that the questionnaire reflects both patients’ and health care professionals’ views, despite the 
reasonable number of items. There is always a risk that other aspects of self-care may be of 
great importance to individual patients. With broad questions, it is easier to cover a problem 
that can then be discussed in more detail in the meeting with the patient. Another strength was 
that the pilot study was based on a sample of patients from three different gastroenterology 
clinics.  
The performance of the questionnaire was strengthened with the process of systematic 
development, using the interview study as a base and various methods during the 
questionnaire development phases I-III (Streiner et al., 2014). The content validity index has 
been criticized as a measure of agreement since it does not account for chance agreement 
(Beckstead, 2009). We used the expert ratings as indicators of the importance of an item and 
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chose experts with various professions to make sure to capture different experiences. Content 
validity index is here used as a measure of the proportion of experts who rated an item as 
often or always relevant and not primarily as a measure of agreement between the experts.  
One limitation is that more cognitive interviews could have been performed to ensure 
that the questions were accurate, understandable, and easy to answer. It is sometimes 
recommended in the literature to do 5-10 cognitive interviews (Collins, 2016). Since the 
cognitive interviews were only one of several evaluations we found three patients to be 
enough. If these interviews had shown problems or a wide variety of problems more 
interviews would have been done. Although the patients participating in the cognitive 
interviews were older than the mean age of the participants in the study, which may have 
influenced their opinions about and expressions of the items, younger patients may have other 
thoughts and be familiar with other expressions. Thus, it is important to further validate the 
questionnaire.  
 
Test-retest stability was evaluated and was shown to be adequate. The three-week 
period for test-retest stability was considered appropriate as a longer period would increase 
the risk of changed self-care due to changes in disease activity (Streiner et al., 2014). In test-
retests of questionnaires there is always a risk that respondents may be influenced by 
answering the first questionnaire, and the answers to the second questionnaire will include 
differences due to an intervention effect. For example, in this case, it is possible that some 
patients got new ideas about self-care from the first questionnaire and therefore changed their 
self-care before the retest questionnaire; however, this was not evident in our results (Bland 
and Altman, 1986).  
 
Practical use of the self-care questionnaire 
The questionnaire is primarily developed for assessment of self-care among patients with 
inflammatory bowel disease for use in both inpatient and outpatient settings. The patients with 
inflammatory bowel disease are in a vulnerable situation and this disease-specific 
questionnaire for self-care assessment may help the health care professionals, in a structured 
way, to meet the patients’ need to strengthen their self-care ability. Based on the pilot study, 
97 % answered all items, which may indicate the usefulness and functionality of the 
structured self-care assessment and may facilitate establishment of a care plan. The 
questionnaire is not intended to function as a scale it is instead aimed to be used for a 
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structured assessment of self-care in the discussion between health care professionals and the 
patient. We suggest that the questionnaire is answered before visiting the clinic, giving the 
patient time to reflect on their self-care needs, which could facilitate the discussion on self-
care during the visit.  
No other self-care questionnaire for patients with inflammatory bowel disease is 
available. It is therefore not possible to validate the new self-care questionnaire against a gold 
standard. To be used in another context the questionnaire needs further validation in groups 
speaking other languages and in other cultures. Future research could examine how patients 
and health care professionals experience the benefit of the questionnaire in clinical practice, 
and also examine the ability of scores to predict differences in clinical outcomes and between 
groups in intervention studies.  
 
Conclusion  
The inflammatory bowel disease–specific self-care questionnaire was developed and 
evaluated by a variety of methods and with the involvement of both patients and health care 
professionals. This resulted in a questionnaire with a reasonable number of questions that are 
considered as relevant by patients and health care professionals for assessing self-care among 
patients with inflammatory bowel disease. 
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